Gulbenkian Institute for Molecular Medicine
Founded in 2023, GIMM is a Portuguese private research foundation for fundamental scientific exploration, born from the merger of the Instituto de Medicina Molecular João Lobo Antunes (iMM) and Instituto Gulbenkian de Ciência (IGC).
WEBSITE: imm.medicina.ulisboa.pt FACEBOOK: www.facebook.com/immolecular TWITTER: www.twitter.com/immolecular The mission of Instituto de Medicina Molecular (IMM) is to foster basic, clinical and translational biomedical research with the aim of contributing to a better understanding of disease mechanisms, developing novel predictive tests, improving diagnostics tools and developing new therapeutic approaches. Located on the campus of the Faculty of Medicine of the University of Lisbon, IMM is a Laboratory Associated to the National Ministry of Science and Higher Education. IMM is mainly supported by national public funds and European Union funds. The research expenditure is also supported by funds obtained from peer reviewed competitive grants, private donations and industrial partnerships. The Academic Medical Centre of Lisbon created as a consortium, brings together IMM, Faculty of Medicine of the University of Lisbon and the Hospital de Santa Maria with the aim of developing an integrated view of medicine, encouraging a crosswise biomedical research both in academic laboratories and clinical practice.
